Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease

Journal of Gastroenterology and Hepatology
Hong MaShu-Yuan Xiao

Abstract

Obesity is one of the risk factors for non-alcoholic fatty liver disease (NAFLD) and a common disease that comprises simple steatosis and non-alcoholic steatohepatitis (NASH), and can eventually lead to liver cirrhosis. Adiponectin is an adipocyte-derived protein that has anti-obesity, antidiabetic and anti-inflammatory properties, and is considered to possess a hepatoprotective function. Its role in the development and progression of NAFLD in morbidly obese patients is unknown. In this study, we examined the expression levels of adiponectin and its receptors in liver biopsies of morbidly obese patients and then determined whether there was an association with the disease severity. Liver biopsies from 30 morbidly obese patients (18 NASH vs 12 steatosis) were analyzed. The needle core biopsies were subjected to routine histological examination and stained immunohistochemically for adiponectin, adiponectin receptor I (adipoRI) and receptor II (adipoRII). The two groups were comparable with respect to body mass index, age and gender distribution. The expression of adiponectin decreased in liver biopsies with NASH as compared to those with simple steatosis (1.61 +/- 0.70 vs 2.25 +/- 0.75, P = 0.028). Spearman's rank correlation coe...Continue Reading

References

Jan 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E E PowellL W Powell
Sep 14, 1999·The American Journal of Gastroenterology·E M BruntB R Bacon
Jul 11, 2001·Biochemical and Biophysical Research Communications·M Yoda-MurakamiM Tomita
Aug 2, 2001·Nature Medicine·A H BergP E Scherer
Jun 7, 2002·The Journal of Clinical Endocrinology and Metabolism·Miyao MatsubaraShinji Katayose
Apr 2, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Giulio MarchesiniMario Rizzetto
Jun 13, 2003·Nature·Toshimasa YamauchiTakashi Kadowaki
Jul 4, 2003·The Journal of Clinical Investigation·Aimin XuGarth J S Cooper
Dec 20, 2003·Current Drug Targets. Immune, Endocrine and Metabolic Disorders·Toshimasa YamauchiTakashi Kadowaki
Jan 16, 2004·Gastroenterology·Yoshihiro KamadaYuji Matsuzawa
Jul 9, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jason M HuiJacob George
Sep 17, 2004·Biochemical and Biophysical Research Communications·Anna M WolfHerbert Tilg
Feb 19, 2005·Journal of Clinical Gastroenterology·Raj VuppalanchiNaga Chalasani
Mar 31, 2005·The Journal of Clinical Endocrinology and Metabolism·Elisabetta BugianesiGiulio Marchesini
Jan 6, 2006·European Journal of Gastroenterology & Hepatology·Cem AygunZeynep Canturk
Mar 30, 2007·Mediators of Inflammation·Mehmet YalnizAhmet Erensoy
May 25, 2007·Biochemical and Biophysical Research Communications·Fumihiko MatsuuraShizuya Yamashita

❮ Previous
Next ❯

Citations

Jul 16, 2011·Clinics and Research in Hepatology and Gastroenterology·Rodolphe Anty, Maud Lemoine
Feb 14, 2009·Journal of Gastroenterology and Hepatology·Alexander HodgeShivakumar Chitturi
Oct 1, 2009·Journal of Gastroenterology and Hepatology·Nicolas Lanthier, Isabelle A Leclercq
Apr 27, 2010·Diabetes, Obesity & Metabolism·Stergios A PolyzosEleni Tsiaousi
Sep 16, 2009·Mediators of Inflammation·Emmanuel A TsochatzisAthanasios J Archimandritis
Oct 18, 2013·International Journal of Molecular Sciences·Akinobu TakakiKazuhide Yamamoto
Feb 23, 2013·World Journal of Gastroenterology : WJG·Carmine Finelli, Giovanni Tarantino
Sep 7, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Michelino Di Rosa, Lucia Malaguarnera
Jun 2, 2009·Journal of Gastroenterology·Katsutoshi TokushigeKeiko Shiratori
Feb 2, 2012·Cellular and Molecular Life Sciences : CMLS·Benjamin T Bikman
May 3, 2014·International Journal of Molecular Sciences·Akinobu TakakiKazuhide Yamamoto
Jun 18, 2010·General and Comparative Endocrinology·Petteri NieminenAnne-Mari Mustonen
May 21, 2014·Journal of Diabetes Investigation·Lydia FoucanFrederic Fumeron
Aug 24, 2013·Biochimie·Jonathan Y XiaPhilipp E Scherer
Jun 7, 2011·The American Journal of Pathology·Mahnoush S ShafieiDon C Rockey
Apr 14, 2016·International Journal of Molecular Sciences·Jiunn-Ming SheenLi-Tung Huang
Jul 18, 2017·Expert Review of Gastroenterology & Hepatology·Daniel ShouhedMazen Noureddin
Sep 28, 2013·World Journal of Hepatology·Michael S KostapanosMoses S Elisaf
Jan 7, 2015·World Journal of Gastroenterology : WJG·Sanja StojsavljevićMarko Duvnjak
Nov 28, 2019·International Journal of Molecular Sciences·Enrica TorrettaCecilia Gelfi
Oct 27, 2015·World Journal of Gastroenterology : WJG·Fabio Salvatore MacalusoSalvatore Petta
Mar 16, 2017·Clinical Journal of Gastroenterology·Hisamitsu Miyaaki, Kazuhiko Nakao
May 26, 2020·Archivum Immunologiae Et Therapiae Experimentalis·Wanvisa UdomsinprasertSittisak Honsawek
Mar 28, 2012·Hormones : International Journal of Endocrinology and Metabolism·Adeeb ShehzadYoung Sup Lee
Jul 12, 2017·European Journal of Endocrinology·Djuro MacutKonstantinos Tziomalos
Jul 29, 2020·International Journal of Molecular Sciences·Misaq HeydariCarmen Peralta
Oct 23, 2020·International Journal of Preventive Medicine·Thi Mong Diep Nguyen
Oct 29, 2020·International Journal of Obesity : Journal of the International Association for the Study of Obesity·Estefania CasanaFatima Bosch
Mar 7, 2021·Journal of Digestive Diseases·Marianna G Mavilia, George Y Wu
Jun 9, 2016·Open Access Macedonian Journal of Medical Sciences·Ahmed SalmanSoheir AbdElfadl

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here